Michael J. Sorich
Flinders University(AU)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Pharmacogenetics and Drug Metabolism, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology
Most-Cited Works
- → Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials(2014)534 cited
- → Low Relative Abundances of the Mucolytic Bacterium Akkermansia muciniphila and Bifidobacterium spp. in Feces of Children with Autism(2011)426 cited
- → Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder(2013)420 cited
- → Elevated Fecal Short Chain Fatty Acid and Ammonia Concentrations in Children with Autism Spectrum Disorder(2012)401 cited
- → Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer(2019)344 cited
- → Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer(2015)323 cited
- → Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift(2023)256 cited
- → Reply: Comment on ‘Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal-antibody therapy for RAS wild-type metastatic colorectal cancer’(2015)230 cited
- → Predicting Human Drug Glucuronidation Parameters: Application of In Vitro and In Silico Modeling Approaches(2004)210 cited
- → Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers(2017)187 cited